open access

Vol 12, No 5 (2008)
Badania kliniczne. Co nowego w hipertensjologii?
Published online: 2008-10-12
Get Citation

The influence of angiotensin receptor antagonist - telmisartan on cardiovascular events in high-risk patients who are intolerant to ACE inhibitors - the TRANSCEND study

Paweł Uruski
Nadciśnienie tętnicze 2008;12(5):389-394.

open access

Vol 12, No 5 (2008)
Badania kliniczne. Co nowego w hipertensjologii?
Published online: 2008-10-12

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

The influence of angiotensin receptor antagonist - telmisartan on cardiovascular events in high-risk patients who are intolerant to ACE inhibitors - the TRANSCEND study

Journal

Arterial Hypertension

Issue

Vol 12, No 5 (2008)

Pages

389-394

Published online

2008-10-12

Bibliographic record

Nadciśnienie tętnicze 2008;12(5):389-394.

Authors

Paweł Uruski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl